Cargando…
Vasculitis update: pathogenesis and biomarkers
Better understanding of the pathogenesis and treatment of primary systemic vasculitides (PSV) has led to the development of many potentially clinically relevant biomarkers. Genome-wide association studies have highlighted that MHC class II polymorphisms may influence the development of particular an...
Autores principales: | Brogan, Paul, Eleftheriou, Despina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769819/ https://www.ncbi.nlm.nih.gov/pubmed/28785984 http://dx.doi.org/10.1007/s00467-017-3597-4 |
Ejemplares similares
-
Therapeutic advances in the treatment of vasculitis
por: Eleftheriou, Despina, et al.
Publicado: (2016) -
Small vessel vasculitis
por: Brogan, Paul, et al.
Publicado: (2009) -
Vasculitis in children
por: Eleftheriou, Despina, et al.
Publicado: (2009) -
Medium-size-vessel vasculitis
por: Dillon, Michael J., et al.
Publicado: (2009) -
The Molecular Biology and Treatment of Systemic Vasculitis in Children
por: Eleftheriou, Despina, et al.
Publicado: (2012)